[Accessed 25 September 2025] Coping with constipation
3.4 Adverse events Three subjects experienced intermittent diarrhea, bloating and nausea before the initiation of semaglutide treatment (timepoint 1), but the symptoms were not severe enough to warrant discontinuation of metformin therapy
Best advice I ever got was to always get copies of all my blood test results
Further reading on GLP-1s and cancer risk: Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes (JAMA) GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity (JAMA) General Disclaimer This document is not intended to address any specific situation or to provide legal, regulatory, financial, or other advice
If youre looking for a gentle, science-backed way to support sexual health, L-Carnitine is worth understanding
Numbers of stroke events, incidence rates (IRs) per 100 person-years and incidence rate ratios (IRRs) for semaglutide compared with DPP4i are reported